Opeolu Adeoye Selected Research

Opeolu Adeoye Research Topics

Disease

32	Stroke (Strokes) 01/2022 - 11/2010
30	Ischemic Stroke 11/2021 - 11/2006
9	Cerebral Hemorrhage 09/2021 - 05/2009
6	Hypertension (High Blood Pressure) 12/2018 - 11/2006
4	Hematoma 01/2021 - 11/2010
3	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2021 - 05/2014
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2021 - 05/2019
2	Subdural Hematoma (Subdural Hemorrhage) 01/2021 - 01/2021
2	Contusions 01/2021 - 01/2021
2	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2021 - 11/2013
2	Hemorrhage 11/2017 - 09/2011
2	Hemorrhagic Stroke 06/2016 - 10/2012
1	Thrombosis (Thrombus) 01/2022
1	Inflammation (Inflammations) 09/2021
1	Infarction (Infarctions) 12/2020
1	COVID-19 01/2020
1	Coma (Comas) 11/2019
1	Delirium 11/2019
1	Multiple Sclerosis 02/2019
1	Neuroinflammatory Diseases 02/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 06/2018
1	Brain Concussion (Cerebral Concussion) 01/2018
1	Craniocerebral Trauma (Head Injury) 01/2018
1	Hyperlipidemias (Hyperlipidemia) 01/2017
1	Heart Diseases (Heart Disease) 01/2017
1	Kidney Diseases (Kidney Disease) 01/2017
1	Acute Kidney Injury (Acute Renal Failure) 01/2017
1	Wounds and Injuries (Trauma) 02/2015
1	Skull Fractures (Skull Fracture) 08/2014

Drug/Important Bio-Agent (IBA)

17	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2021 - 11/2009
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 09/2012
5	Eptifibatide (Integrilin)FDA Link 10/2021 - 09/2013
5	Antihypertensive Agents (Antihypertensives)IBA 12/2018 - 11/2006
4	AnticoagulantsIBA 01/2022 - 11/2010
3	Proteins (Proteins, Gene)FDA Link 07/2017 - 10/2012
2	MetalloproteinsIBA 07/2017 - 10/2012
2	MetalsIBA 07/2017 - 10/2012
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 04/2016 - 09/2011
2	Warfarin (Coumadin)FDA LinkGeneric 09/2011 - 05/2009
1	boldenone undecylenate (Equipoise)IBA 01/2022
1	argatroban (MPQA)FDA Link 10/2021
1	MicroRNAs (MicroRNA)IBA 09/2021
1	Interleukin-8 (Interleukin 8)IBA 09/2021
1	Messenger RNA (mRNA)IBA 09/2021
1	ORALIT (ORS)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 07/2019
1	Antidepressive Agents (Antidepressants)IBA 05/2019
1	Mitoxantrone (Novantrone)FDA LinkGeneric 02/2019
1	Rituximab (Mabthera)FDA Link 02/2019
1	Fingolimod Hydrochloride (FTY720)FDA Link 02/2019
1	Glatiramer Acetate (Copaxone)FDA Link 02/2019
1	Interferon beta-1b (Betaseron)FDA Link 02/2019
1	Interferon beta-1a FDA Link 02/2019
1	ocrelizumabIBA 02/2019
1	teriflunomideIBA 02/2019
1	Daclizumab (Zenapax)FDA Link 02/2019
1	Alemtuzumab (Campath)FDA Link 02/2019
1	Dimethyl FumarateIBA 02/2019
1	Natalizumab (Tysabri)FDA Link 02/2019
1	Protein CIBA 01/2019
1	Neuroprotective AgentsIBA 01/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2018
1	Calcium Gluconate (CBG)IBA 10/2018
1	Hydrocortisone (Cortisol)FDA LinkGeneric 10/2018
1	ProteomeIBA 10/2018
1	Glucose (Dextrose)FDA LinkGeneric 08/2018
1	CholesterolIBA 06/2018
1	Selenoprotein PIBA 07/2017
1	L-Type Calcium Channels (Dihydropyridine Receptor)IBA 07/2017
1	Selenoproteins (Selenoprotein)IBA 07/2017
1	Inwardly Rectifying Potassium Channels (Inward Rectifier Potassium Channels)IBA 07/2017
1	Transferrin (beta 2 Transferrin)IBA 07/2017
1	tau-tubulin kinaseIBA 07/2017
1	Glutathione PeroxidaseIBA 07/2017
1	LipidsIBA 01/2017
1	Coloring Agents (Dyes)IBA 01/2017
1	TroponinIBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	PlasminogenIBA 10/2016
1	ApolipoproteinsIBA 06/2016
1	Apolipoprotein A-I (Apolipoprotein A1)IBA 06/2016
1	Matrix Metalloproteinases (MMPs)IBA 06/2016
1	Aryldialkylphosphatase (Paraoxonase)IBA 06/2016
1	Apolipoprotein C-I (Apolipoprotein C1)IBA 06/2016
1	Apolipoprotein C-IIIIBA 06/2016
1	Anticoagulant Reversal AgentsIBA 12/2015
1	Glycoproteins (Glycoprotein)IBA 09/2015
1	AlbuminsIBA 02/2015

Therapy/Procedure

17	Therapeutics 01/2022 - 11/2010
8	Thrombectomy 01/2021 - 12/2009
3	Thrombolytic Therapy 11/2021 - 11/2006
2	Secondary Prevention 01/2019 - 12/2018
1	Critical Care (Surgical Intensive Care) 01/2021
1	Deep Sedation 11/2019
1	Aftercare (After-Treatment) 01/2018
1	Length of Stay 01/2017
1	Intravenous Administration 01/2016
1	Time-to-Treatment 01/2016
1	Anticoagulation Reversal 12/2015
1	Craniotomy 02/2015